MELT PHARMACEUTICALS, INC.

Profile

Company Names

MELT PHARMACEUTICALS, INC.

Addresses

5511 VIRGINIA WAY, SUITE 300, BRENTWOOD, TN 37027

6 CADILLAC DRIVE, SUITE 320, BRENTWOOD, TN 37027

12264 EL CAMINO REAL, SUITE 350, SAN DIEGO, CA 92130

Phone Numbers

8587044042
629-802-9555
858-704-4042

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$53,727,450.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-07-28 
$42,292,450.00 
$47,763,600.00 
$5,471,150.00 
Equity 
1
2019-01-30 
$11,435,000.00 
$25,750,000.00 
$14,315,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BAUM 
DIRECTOR
IMPRIMIS PHARMACEUTICALS, INC.   |  ETON PHARMACEUTICALS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  MELT PHARMACEUTICALS, INC.   |  SURFACE OPHTHALMICS, INC.
JOHN 
 
BERDAHL 
DIRECTOR
EQUINOX, INC.   |  MELT PHARMACEUTICALS, INC.   |  EQUINOX OPHTHALMIC, INC.   |  BALANCE OPHTHALMICS, INC.
ANDREW 
 
BOLL 
DIRECTOR
IMPRIMIS PHARMACEUTICALS, INC.   |  ETON PHARMACEUTICALS, INC.   |  MELT PHARMACEUTICALS, INC.
LARRY 
 
DILLAHA 
DIRECTOR, EXECUTIVE OFFICER
INVASC THERAPEUTICS, INC.   |  INSYS THERAPEUTICS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  MELT PHARMACEUTICALS, INC.
GREGORY 
 
MADISON 
EXECUTIVE OFFICER, DIRECTOR
MELT PHARMACEUTICALS, INC.
BRAD 
 
OSBORNE 
EXECUTIVE OFFICER
MELT PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-08
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2024-03-11
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2024-02-12
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2024-01-09
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2023-12-11
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2023-11-13
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2023-10-13
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2023-09-12
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2023-08-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-28 
2019-04-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-30 
2019-02-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION
NONE
NEWBRIDGE SECURITIES CORPORATION
104065
LAKE STREET CAPITAL MARKETS, LLC
164447
NONE
NONE
LAKE STREET CAPITAL MARKETS, LLC
164447